214 related articles for article (PubMed ID: 33525423)
21. Does the quality of endoscopic equipment influence the recurrence rate after photodynamic diagnosis-assisted transurethral resection of bladder tumor?
Nakagawa R; Nohara T; Kano H; Makino T; Naito R; Iwamoto H; Yaegashi H; Kawaguchi S; Shigehara K; Izumi K; Mizokami A
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104023. PubMed ID: 38401816
[TBL] [Abstract][Full Text] [Related]
22. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer.
Inoue K; Fukuhara H; Shimamoto T; Kamada M; Iiyama T; Miyamura M; Kurabayashi A; Furihata M; Tanimura M; Watanabe H; Shuin T
Cancer; 2012 Feb; 118(4):1062-74. PubMed ID: 21773973
[TBL] [Abstract][Full Text] [Related]
23. Primary Complete Transurethral Resection of Bladder Tumor Using Photodynamic Diagnosis for High-Risk Nonmuscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary?
Tadrist A; Gondran-Tellier B; McManus R; Al Balushi K; Akiki A; Gaillet S; Delaporte V; Karsenty G; Lechevallier E; Boissier R; Baboudjian M
J Endourol; 2021 Jul; 35(7):1042-1046. PubMed ID: 33626963
[No Abstract] [Full Text] [Related]
24. Comparison of PDD-TURBT alone versus white light TURBT plus intravesical BCG therapy: A propensity-score matching study.
Miyakawa J; Yamada Y; Hakozaki Y; Makino K; Kamei J; Taguchi S; Kawai T; Akiyama Y; Yamada D; Kume H
Photodiagnosis Photodyn Ther; 2024 Jun; 48():104254. PubMed ID: 38901718
[TBL] [Abstract][Full Text] [Related]
25. The Japanese health care system-based cost-effectiveness of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer.
Nishimura N; Miyake M; Miyamoto T; Tomizawa M; Shimizu T; Morizawa Y; Hori S; Gotoh D; Nakai Y; Torimoto K; Tanaka N; Fujimoto K
Jpn J Clin Oncol; 2023 Mar; 53(4):343-348. PubMed ID: 36585780
[TBL] [Abstract][Full Text] [Related]
26. [Initial Experience of Photodynamic Diagnosis-Assisted Transurethral Resection of Bladder Tumor (PDD-TURBT)].
Sugino Y; Nishikawa K; Kato M; Sasaki T; Kato M; Masui S; Yoshio Y; Kanda H; Sugimura Y; Inoue T
Hinyokika Kiyo; 2021 Jul; 67(7):303-308. PubMed ID: 34353010
[TBL] [Abstract][Full Text] [Related]
27. Reduced Recurrence Rates Are Associated with Photodynamic Diagnostics Compared to White Light after Extended Transurethral Resection of Bladder Tumors.
Marquardt A; Richterstetter M; Taubert H; Hartmann A; Wullich B; Lieb V; Bellut L; Wach S; Apel H
Life (Basel); 2022 Apr; 12(5):. PubMed ID: 35629309
[TBL] [Abstract][Full Text] [Related]
28. Conventional white light imaging-assisted transurethral resection of bladder tumour (TURBT) versus IMAGE1S-assisted TURBT in non-muscle-invasive bladder cancer patients: trial protocol and 18 months results.
de la Rosette J; Martov A; Hurle R; Favre G; Mamoulakis C; Castanheira de Oliveira M; Stenzl A; Linares-Espinós E; Trelles Guzmán CR; Gravas S; Knoll T; Boz MY; Herrmann T; Laguna P
World J Urol; 2022 Mar; 40(3):727-738. PubMed ID: 34741631
[TBL] [Abstract][Full Text] [Related]
29. Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer.
Tae BS; Jeong CW; Kwak C; Kim HH; Moon KC; Ku JH
PLoS One; 2017; 12(12):e0189354. PubMed ID: 29244843
[TBL] [Abstract][Full Text] [Related]
30. Incidence and predictors of intraoperative hypotension during transurethral bladder tumor resection with oral 5-aminolevulinic acid.
Ishikawa Y; Tanaka H; Fujiwara M; Nakamura Y; Fukuda S; Waseda Y; Yoshida S; Yokoyama M; Fujii Y
Int J Urol; 2024 Mar; 31(3):238-244. PubMed ID: 37986203
[TBL] [Abstract][Full Text] [Related]
31. Variations in photodynamic diagnosis for bladder cancer due to the quality of endoscopic equipment.
Nohara T; Kamijima T; Fukuda R; Kano H; Shimada T; Nakano T; Kato Y; Kadomoto S; Iwamoto H; Yaegashi H; Iijima M; Kawaguchi S; Shigehara K; Izumi K; Kadono Y; Mizokami A
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102628. PubMed ID: 34808397
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic diagnosis-assisted transurethral resection using oral 5-aminolevulinic acid decreases residual cancer and improves recurrence-free survival in patients with non-muscle-invasive bladder cancer.
Taoka R; Matsuoka Y; Yamasaki M; Kani N; Honda T; Harada S; Tohi Y; Kato T; Okazoe H; Tsunemori H; Ueda N; Sugimoto M
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102838. PubMed ID: 35381368
[TBL] [Abstract][Full Text] [Related]
33. Blue vs white light for transurethral resection of non-muscle-invasive bladder cancer: an abridged Cochrane Review.
Maisch P; Koziarz A; Vajgrt J; Narayan V; Kim MH; Dahm P
BJU Int; 2022 Dec; 130(6):730-740. PubMed ID: 35238145
[TBL] [Abstract][Full Text] [Related]
34. Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011.
May M; Fritsche HM; Vetterlein MW; Bastian PJ; Gierth M; Nuhn P; Aziz A; Fisch M; Stief CG; Hohenfellner M; Wirth MP; Novotny V; Hakenberg OW; Noldus J; Gilfrich C; Bolenz C; Burger M; Brookman-May SD;
World J Urol; 2017 Feb; 35(2):245-250. PubMed ID: 27300339
[TBL] [Abstract][Full Text] [Related]
35. [A systematic review and meta-analysis to assess the recurrence-free survival in non-muscle invasive bladder cancer after transurethral resection guided by 5-aminolevulinic acid-induced photodynamic diagnosis compared with white-light transurethral resect].
Rolevich AI; Evmenenko AA
Urologiia; 2016 Aug; (4):137-146. PubMed ID: 28247741
[TBL] [Abstract][Full Text] [Related]
36. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
[TBL] [Abstract][Full Text] [Related]
37. Identification of risk factors associated with oral 5-aminolevulinic acid-induced hypotension in photodynamic diagnosis for non-muscle invasive bladder cancer: a multicenter retrospective study.
Fukuhara H; Nohara T; Nishimoto K; Hatakeyama Y; Hyodo Y; Okuhara Y; Oyama M; Mizokami A; Inoue K; Matsuyama H;
BMC Cancer; 2021 Nov; 21(1):1223. PubMed ID: 34774000
[TBL] [Abstract][Full Text] [Related]
38. Photodynamic Diagnosis-Assisted En Bloc Transurethral Resection of Bladder Tumor for Nonmuscle Invasive Bladder Cancer: Short-Term Oncologic and Functional Outcomes.
Miyake M; Nishimura N; Fujii T; Miyamoto T; Iida K; Hori S; Morizawa Y; Gotoh D; Nakai Y; Anai S; Torimoto K; Tanaka N; Fujimoto K
J Endourol; 2021 Mar; 35(3):319-327. PubMed ID: 32940054
[No Abstract] [Full Text] [Related]
39. Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
Kobayashi K; Matsuyama H; Kawai T; Ikeda A; Miyake M; Nishimoto K; Matsushita Y; Komura K; Abe T; Kume H; Nishiyama H; Fujimoto K; Oyama M; Miyake H; Inoue K; Mitsui T; Kawakita M; Ohyama C; Mizokami A; Kuroiwa H
Int J Urol; 2022 Jul; 29(7):632-638. PubMed ID: 35293022
[TBL] [Abstract][Full Text] [Related]
40. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature.
Rink M; Babjuk M; Catto JW; Jichlinski P; Shariat SF; Stenzl A; Stepp H; Zaak D; Witjes JA
Eur Urol; 2013 Oct; 64(4):624-38. PubMed ID: 23906669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]